Vietnam charts path to modern pharma chemical sector by 2045

Vietnam has outlined a comprehensive strategy to transform its pharmaceutical chemical sector, targeting the development of a modern, technology-driven industry by 2045. The initiative prioritizes achieving technological mastery and capability in critical pharmaceutical manufacturing areas within the next seven years.

Under the framework, Vietnam aims to acquire and transfer advanced technologies needed to produce active pharmaceutical ingredients (APIs), starting materials, chemical intermediates, and excipients by 2030. These components form the backbone of pharmaceutical production and are currently heavily dependent on imports from other countries.

The strategy reflects Vietnam's broader ambitions to reduce reliance on imported pharmaceutical chemicals while positioning the country as a competitive regional manufacturing hub. By establishing domestic production capabilities for essential pharmaceutical components, Vietnam seeks to enhance supply chain security and reduce costs for local pharmaceutical manufacturers.

The push toward a modernized pharmaceutical chemical industry comes as Vietnam's healthcare and pharmaceutical sectors continue to attract significant investment and growth. The initiative aligns with Vietnam's economic diversification goals and efforts to develop higher-value manufacturing capabilities across key industries.